ArticleCancer biomarkers : section A of Disease markers2025
Identification of key genes related to cancer associated fibroblasts in neuroblastoma: A comprehensive bioinformatics approach.
Article in Cancer biomarkers : section A of Disease markers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- MYCN-driven metabolic remodelling of the tumour microenvironment in neuroblastoma: implications for stromal biology and CAF heterogeneity.Cancer metastasis reviews · 2026Review
- Arginine-axis transcriptomics define three neuroblastoma subtypes and a fixed four-gene prognostic signature with immune correlations.Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundNeuroblastoma (NB) is one of the most common and aggressive pediatric solid tumors, characterized by a highly complex pathogenesis. Within the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) constitute a major cell population and play a pivotal role in facilitating communication among various stromal cells. However, the specific functions and contributions of CAFs in NB remain incompletely understood.ObjectiveTo investigate the impact of CAFs-related genes on the prognosis of NB, we developed a risk model to facilitate the diagnosis and prognostication of patients.MethodsIn this study, a CAFs gene prognostic model for NB was established using single-cell analysis and genomic sequencing data. The effectiveness of this prognostic model was subsequently evaluated through the development of a nomogram, immune infiltration analysis, drug prediction, and gene set enrichment analysis. Ultimately, the expression levels of the identified key genes were experimentally validated in NB tissues.ResultsA novel prognostic model for CAFs related to NB prognosis was established through single-cell analysis and transcriptome dataset analysis. The prognosis of the high-risk group was worse than that of the low-risk group. The validity of the model was confirmed by nomogram, drug sensitivity analysis, and immune infiltration methods. Finally, the high expression of the key gene STEAP2 in NB tissues was verified by experiments.ConclusionsThe study introduces a new predictive model that uses CAF markers to forecast the prognosis of NB. STEAP2 plays a key role in identifying high-risk neuroblastoma and may become a potential therapeutic target for NB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.